fanasil, pyrimethamine drug combination has been researched along with Toxoplasmosis, Congenital in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (7.14) | 18.7374 |
1990's | 2 (14.29) | 18.2507 |
2000's | 5 (35.71) | 29.6817 |
2010's | 6 (42.86) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aoun, K; Ben Abdallah, R; Bouhlel, S; Bouratbine, A; Maatoug, R; Souissi, O | 1 |
Charpiat, B; Corvaisier, S; Dupont, D; Leboucher, G; Peyron, F; Teil, J; Vial, T; Wallon, M | 1 |
Chemla, C; Villena, I | 1 |
Dupont, D; Peyron, F | 1 |
Assouline, C; Ayoubi, JM; Berrebi, A; Berry, A; Bessières, MH; Cambus, JP; Cassaing, S; Fillaux, J; Magnaval, JF | 1 |
Assouline, C; Ayoubi, JM; Berrébi, A; Bessières, MH; Cassaing, S; Lathière, M; Minville, V | 1 |
Pradhan, P; Rai, SK; Sharma, A; Shrestha, RK | 1 |
Chemla, C; Dupouy, D; Jaussaud, R; Leroux, B; Millart, H; Pinon, JM; Quereux, C; Rémy, G; Simon, N; Trenque, T; Urien, S; Villena, I | 1 |
Binquet, C; Denis, P; Fleury, J; Garweg, JG; Kodjikian, L; Peyron, F; Wallon, M | 1 |
Chemla, C; Pinon, JM; Trenque, T; Villena, I | 1 |
Faber, C; Garin, JP; Maisonneuve, H; Piens, MA | 1 |
Czarnecka-Rudnik, D; Stanek-Bazylko, F | 1 |
Aubert, D; Bonhomme, A; Chemla, C; Dupouy, D; Guenounou, M; Leroux, B; Pinon, JM; Pluot, M; Quereux, C; Schmit, G; Talmud, M; Trenque, T; Villena, I | 1 |
Aubert, D; Chemla, C; Dupouy, D; Leroux, B; Pinon, JM; Villena, I | 1 |
1 trial(s) available for fanasil, pyrimethamine drug combination and Toxoplasmosis, Congenital
Article | Year |
---|---|
[Clinical view of toxoplasmosis in children--personal observations].
Topics: Adolescent; Anti-Infective Agents; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique; Follow-Up Studies; Humans; Infant; Infant, Newborn; Mass Screening; Pyrimethamine; Serologic Tests; Spiramycin; Sulfadoxine; Toxoplasmosis; Toxoplasmosis, Congenital; Trimethoprim, Sulfamethoxazole Drug Combination | 1997 |
13 other study(ies) available for fanasil, pyrimethamine drug combination and Toxoplasmosis, Congenital
Article | Year |
---|---|
[Management of Toxoplasmic Seroconversion in the Third Trimester of Pregnancy in Tunisia].
Topics: Adult; Drug Combinations; Female; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Third; Prenatal Diagnosis; Pyrimethamine; Seroconversion; Sulfadoxine; Toxoplasmosis; Toxoplasmosis, Congenital; Tunisia; Young Adult | 2018 |
Treatment of Congenital Toxoplasmosis: Safety of the Sulfadoxine-Pyrimethamine Combination in Children Based on a Method of Causality Assessment.
Topics: Antimalarials; Causality; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Male; Pregnancy; Pyrimethamine; Retrospective Studies; Sulfadoxine; Toxoplasmosis, Congenital | 2016 |
Sulfadoxine-Pyrimethamine Combination in Congenital Toxoplasmosis.
Topics: Antimalarials; Drug Combinations; Drug Therapy, Combination; Humans; Pyrimethamine; Sulfadoxine; Toxoplasmosis, Congenital | 2017 |
In Reply: Sulfadoxine-Pyrimethamine Combination in Congenital Toxoplasmosis.
Topics: Antimalarials; Drug Combinations; Drug Therapy, Combination; Humans; Pyrimethamine; Sulfadoxine; Toxoplasmosis, Congenital | 2017 |
Diagnosis of congenital toxoplasmosis: prenatal and neonatal evaluation of methods used in Toulouse University Hospital and incidence of congenital toxoplasmosis.
Topics: Amniocentesis; Animals; Antibodies, Protozoan; DNA, Protozoan; Drug Combinations; Enzyme-Linked Immunosorbent Assay; Female; France; Hospitals, University; Humans; Immunoglobulin A; Immunoglobulin G; Incidence; Infant, Newborn; Polymerase Chain Reaction; Predictive Value of Tests; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Diagnosis; Pyrimethamine; Sensitivity and Specificity; Spiramycin; Sulfadoxine; Toxoplasma; Toxoplasmosis, Congenital | 2009 |
Long-term outcome of children with congenital toxoplasmosis.
Topics: Age Factors; Child; Child Development; Child, Preschool; Chorioretinitis; Cohort Studies; Drug Combinations; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Monitoring, Physiologic; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Pyrimethamine; Risk Assessment; Spiramycin; Sulfadoxine; Time Factors; Toxoplasmosis, Congenital; Toxoplasmosis, Ocular | 2010 |
First case of congenital toxoplasmosis from Nepal.
Topics: Antimalarials; Antiprotozoal Agents; Drug Combinations; Fatal Outcome; Humans; Infant; Male; Nepal; Pyrimethamine; Sulfadoxine; Toxoplasmosis, Congenital | 2011 |
Population pharmacokinetics of pyrimethamine and sulfadoxine in children with congenital toxoplasmosis.
Topics: Adolescent; Child; Child, Preschool; Chromatography, High Pressure Liquid; Drug Combinations; Female; Humans; Infant; Infant, Newborn; Male; Pyrimethamine; Sulfadoxine; Toxoplasmosis, Congenital | 2004 |
Ocular manifestations in congenital toxoplasmosis.
Topics: Adolescent; Adult; Antibodies, Protozoan; Antiprotozoal Agents; Child; Child, Preschool; Chorioretinitis; Drug Combinations; Female; Follow-Up Studies; Humans; Infant; Male; Pyrimethamine; Sulfadoxine; Toxoplasmosis, Congenital; Toxoplasmosis, Ocular; Vision Disorders | 2006 |
[Prenatal treatment of congenital toxoplasmosis].
Topics: Antimalarials; Drug Combinations; Female; Follow-Up Studies; Humans; Leucovorin; Neutropenia; Pregnancy; Prenatal Care; Pyrimethamine; Sulfadoxine; Toxoplasmosis, Congenital; Vitamin B Complex | 2005 |
[Congenital toxoplasmosis. Tolerability of the sulfadoxine-pyrimethamine combination. 24 cases].
Topics: Child, Preschool; Drug Combinations; Female; Humans; Infant; Leucovorin; Male; Pyrimethamine; Sulfadoxine; Sulfanilamides; Toxoplasmosis, Congenital | 1984 |
Pyrimethamine-sulfadoxine treatment of congenital toxoplasmosis: follow-up of 78 cases between 1980 and 1997. Reims Toxoplasmosis Group.
Topics: Adolescent; Antimalarials; Child; Child, Preschool; Chorioretinitis; Drug Administration Schedule; Drug Combinations; Follow-Up Studies; Humans; Infant; Infant, Newborn; Leucovorin; Pyrimethamine; Sulfadoxine; Toxoplasmosis, Congenital | 1998 |
[Frequency of persistent or transitory serologic negative values in infants with congenital toxoplasmosis. Experience of the Reims Toxoplasmosis Group (1980-1997)].
Topics: Animals; Antibodies, Protozoan; Drug Combinations; Follow-Up Studies; Humans; Infant; Infant, Newborn; Pyrimethamine; Spiramycin; Sulfadoxine; Toxoplasma; Toxoplasmosis, Congenital | 2002 |